{"title":"A Probabilistic Approach to Evaluate the Likelihood of Artificial Genetic Modification and Its Application to SARS-CoV-2 Omicron Variant","authors":"H. Kakeya, Y. Matsumoto","doi":"10.2197/ipsjtbio.15.22","DOIUrl":null,"url":null,"abstract":"A method to find a probability that a given bias of mutations occur naturally is proposed to test whether a newly detected virus is a product of natural evolution or a product of non-natural process such as genetic manipulation. The probability is calculated based on the neutral theory of molecular evolution and binominal distribution of non-synonymous (N) and synonymous (S) mutations. Though most of the conventional analyses, including dN/dS analysis, assume that any kinds of point mutations from a nucleotide to another nucleotide occurs with the same probability, the proposed model takes into account the bias in mutations, where the equilibrium of mutations is considered to estimate the probability of each mutation. The proposed method is applied to evaluate whether the Omicron variant strain of SARS-CoV-2, whose spike protein includes 29 N mutations and only one S mutation, can emerge through natural evolution. The result of binomial test based on the proposed model shows that the bias of N/S mutations in the Omicron spike can occur with a probability of 2.0 × 10−3 or less. Even with the conventional model where the probabilities of any kinds of mutations are all equal, the strong N/S mutation bias in the Omicron spike can occur with a probability of 3.7 × 10−3, which means that the Omicron variant is highly likely a product of non-natural process including artifact. © 2022 Information Processing Society of Japan.","PeriodicalId":38959,"journal":{"name":"IPSJ Transactions on Bioinformatics","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IPSJ Transactions on Bioinformatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2197/ipsjtbio.15.22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0
评估人工基因改造可能性的概率方法及其在SARS-CoV-2组粒变异中的应用
提出了一种方法来确定给定的突变偏差自然发生的概率,以测试新检测到的病毒是自然进化的产物还是非自然过程(如遗传操作)的产物。概率计算基于分子进化中性理论和非同义(N)和同义(S)突变的二项分布。虽然大多数传统分析,包括dN/dS分析,都假设从一个核苷酸到另一个核苷酸的任何种类的点突变以相同的概率发生,但该模型考虑了突变的偏差,其中考虑了突变的平衡来估计每个突变的概率。该方法用于评估刺突蛋白包含29个N突变和1个S突变的SARS-CoV-2的Omicron变异株是否可以通过自然进化产生。基于该模型的二项检验结果表明,在Omicron峰中N/S突变发生偏差的概率为2.0 × 10−3或更小。即使在任何类型突变的概率都相等的传统模型中,强N/S突变偏差在欧米克隆尖峰中的发生概率为3.7 × 10−3,这意味着欧米克隆变体很可能是包括人工制品在内的非自然过程的产物。©2022日本信息处理学会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。